Bismarck Cancer Center
New Prostate Treatment at the Bismarck Cancer Center

New High Dose (HDR) Prostate Brachytherapy

New (HDR) Prostate Brachytherapy is a type of minimally invasive local treatment, similar to prostate seed implantation, which can be used for men with low risk, intermediate risk, or high risk prostate cancer. In contrast to seed implantation, HDR brachytherapy allows for up-front dose planning optimization prior to dose deposition and enables our doctors to more precisely minimize dose to the urethra and rectum while optimizing dose deposition to the prostate. This technique also avoids residual radioactive materials in patients, and thus prevents radiation exposure to family members, pets, and the public.

Logistically, the procedure is a same-day, outpatient procedure with light anesthesia. Treatment involves the placement of catheters into the prostate gland using ultrasound guidance. Advanced treatment planning is then undertaken to individualize treatment parameters based on patient anatomy. Finally, a radioactive source travels through the catheters to deliver radiotherapy over the course of 15-20 minutes. This technique provides precise, high-dose treatment over a short time interval and with minimal side effects. We are confident this new treatment option will be instrumental in improving the way we treat prostate cancer, and will lead to better patient outcomes.

Return to News Section